Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Revenue (2018 - 2025)

Historic Revenue for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $166.0 million.

  • 10x Genomics' Revenue rose 61.14% to $166.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $642.8 million, marking a year-over-year increase of 524.54%. This contributed to the annual value of $642.8 million for FY2025, which is 524.54% up from last year.
  • Per 10x Genomics' latest filing, its Revenue stood at $166.0 million for Q4 2025, which was up 61.14% from $149.0 million recorded in Q3 2025.
  • 10x Genomics' Revenue's 5-year high stood at $184.0 million during Q4 2023, with a 5-year trough of $105.8 million in Q1 2021.
  • Over the past 5 years, 10x Genomics' median Revenue value was $147.9 million (recorded in 2023), while the average stood at $144.0 million.
  • Per our database at Business Quant, 10x Genomics' Revenue skyrocketed by 16999.65% in 2021 and then crashed by 1030.44% in 2024.
  • Over the past 5 years, 10x Genomics' Revenue (Quarter) stood at $143.5 million in 2021, then grew by 8.85% to $156.2 million in 2022, then rose by 17.76% to $184.0 million in 2023, then dropped by 10.3% to $165.0 million in 2024, then increased by 0.61% to $166.0 million in 2025.
  • Its Revenue stands at $166.0 million for Q4 2025, versus $149.0 million for Q3 2025 and $172.9 million for Q2 2025.